AGBT 2023: Experience the only true spatial multiomics solution
AGBT 2023 Scientific Presentation Recordings
True Spatial Multiomics in Action
True spatial multiomics: One section, two analytes
Niro Ramachandran, Ph.D., Chief Business Officer, Akoya Biosciences and Julia Kennedy-Darling, Ph.D., VP, Innovation, Akoya Biosciences
(18 min) Hear the results of a groundbreaking study that demonstrated how multiomics reveals a radically new view of cancer by combining cell typing and functional mapping.
Video
A multiomic spatial phenotypic atlas of triple-negative breast cancer in women of African ancestry
Jasmine Plummer, Ph.D. Director, St. Jude Center for Spatial Omics, St. Jude Children’s Research Hospital
(6 min) Learn how the team at St. Jude’s created a spatial atlas using a multiomic (protein + RNA) imaging approach to profile TNBC of women with different African Ancestry.
Video
Rapid whole-slide spatial analysis of FFPE tissues with true multiomic panels enables the discovery of key cellular niches
Julia Kennedy-Darling, Ph.D., VP, Innovation, Akoya Biosciences
(3 min) Combining RNA chemistry with protein chemistry on the same section of a slide with the PhenoCycler-Fusion provides more exquisite cell typing and a stronger understanding of the specific functional states of each cell. View Poster
Video
Generating Insights into Immunotherapy Responses
Spatial Multiomics: Insights into immunotherapy response via mapping patient journey
Oliver Braubach, Ph.D., Director of Applications, Akoya Biosciences and Arutha KulaSinghe, Ph.D., NHMRC Research Fellow and Group Leader, University of Queensland Diamantina Institute
(15 min) Hear how Arutha Kulasinghe used ultrahigh-plex spatial phenotyping of tumor and immune cell interactions to define variations in the response of head and neck cancers to immunotherapy with extraordinary clarity.
Video
High-speed multiomic spatial phenotyping of immunotherapy responses in head and neck cancer
Oliver Braubach, Ph.D., Director of Applications, Akoya Biosciences
(3 min) Learn how multiomic spatial phenotyping was used to produce a uniquely comprehensive analysis of the patient’s tumor microenvironment (TME) and how it explains partial response to immune checkpoint inhibitor therapy. View Poster
Video
Mechanisms of metaplastic progression to adenocarcinoma revealed by high-speed multiomic spatial phenotyping of FFPE human samples
John Hickey, Ph.D., American Cancer Society Postdoctoral Fellow, Stanford University
(15 min) Listen to John Hickey share how he imaged 54 antibodies on the PhenoCycler-Fusion to dissect epithelial microenvironment in FFPE esophagus tissue.
Video
